Providence Cancer Institute shares updates on advances in care for melanoma patients

Providence Cancer Institute shares updates on advances in care for melanoma patients

In early October, Providence Cancer Institute of Oregon and AIM at Melanoma Foundation held a virtual patient education event for people with melanoma, plus their family and friends.

Watch full presentations here

Talks included: 

  • "Basics of Clinical Trials,” presented by Chris Fountain, RN, Clinician-Research, Providence Cancer Institute (video)

  • “Case Studies Illustrating Recent Advances in Medical Care,” presented by Brendan D. Curti, M.D., Medical Oncologist, Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)

  • “New Treatments Under Development in Melanoma,” presented by Matthew H. Taylor, M.D., Medical Oncologist, Co-Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)

  • “Communication with Family & Friends,” presented by Dawn Brucker, LCSW, OSW-C, Oncology Social Worker, Providence Cancer Institute (video)

We host a variety of classes, educational talks, and other events throughout the year. Learn more at providence.org.

Related news

Multi-indication clinical trials help evaluate new medications for future treatments

Studies will evaluate combination therapies for two types of melanoma

Melanoma studies: can adjuvant immunotherapy improve recurrence-free survival?

10/25/2022
Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.
7/13/2022
UV ray exposure contributes to millions of skin cancer cases each year. Learn how to protect your skin to reduce your sunburn and skin cancer risks.
6/10/2022
Although skin protection is important year-round, the summer is a good time to review helpful tips and tricks to help keep your skin safe while you enjoy the outdoors.
6/8/2022
Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.